正丹股份：12月9日召开董事会会议

Group 1 - The company Zhengdan Co., Ltd. (SZ 300641) announced that its fifth board meeting was held on December 9, 2025, via telecommunication, where it reviewed the proposal to convene the third extraordinary shareholders' meeting of 2025 [1] - For the first half of 2025, the company's revenue composition is entirely from the petrochemical industry, accounting for 100.0% [1] - As of the report date, Zhengdan Co., Ltd. has a market capitalization of 9.7 billion yuan [1] Group 2 - The article highlights a significant issue in the pharmaceutical industry, reporting the first case of pregabalin abuse leading to addiction in China, raising concerns about the accessibility of prescription drugs without proper medical records [1]